The COVID-19 crisis brought critical care medicine into the global spotlight and re-exposed systemic gaps in patient care. Four years after the initial surge of cases, the Max Harry Weil Institute for Critical Care Research and Innovation at the University of Michigan is asking the question: where do we go from here?
Read MoreUniversity of Michigan researchers examine if molecular compounds in exhaled breath could lead to improved diagnosis and tracking of acute respiratory distress syndrome (ARDS).
Read MoreResearchers discuss recent study on physician-aided AI systems published Dr. Negar Farzaneh and team.
Read MoreWeil Institute members form regional consortium to study critical illness syndromes and empower future research efforts.
Read MoreIn a new study published in npj Digital Medicine, Weil Institute researchers find that using artificial intelligence in a way that collaborates with physicians, rather than replaces them, could result in higher diagnostic accuracy while also potentially reducing physician workload.
Read MoreA recent study by Weil Institute investigators was featured on the Michigan Medicine Health Lab blog.
Read MoreThe U.S. Food and Drug Administration (FDA) has approved an Emergency Use Authorization (EUA) for the Aerosolve negative pressure procedure tent built in response to the COVID-19 pandemic.
Read MoreNovel large animal research models developed at the University of Michigan Center for Integrative Research in Critical Care fill a crucial gap in the translational study of life-threatening critical illness and injury.
Read More